SeCure trial data show ablation of incompetent perforator veins benefits patients

Kathleen Gibson (Bellevue, USA), one of the principal investigators of the SeCure trial, presented its results at the ACP 2018 annual congress. “More than closure rates, it is the quality of life findings from this trial that are important take-homes for physicians,” Gibson told Venous News.

Gibson, Kathleen

Dr Kathleen Gibson is a vascular surgeon, treating both venous and arterial disorders at Lake Washington Vascular Surgeons, Bellevue, USA. She is also a prominent clinical researcher in the venous field, and plays an active role in a range of venous and vascular societies, as well as being involved in the development of standardisation of definitions and tools for treating pelvic venous disease. She specialises in aortic stent grafts, peripheral angioplasty and stents (venous and arterial), endothermal heat ablation for superficial venous insufficiency, and sclerotherapy

Add comment

Editor’s Venous Pick

    Subscribeto receive the very best in medical videos